🇺🇸 FDA

Company profile · Sponsor

H.A.C.

H.A.C. Pharma

EAF1C4F · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

H.A.C. (EAF1C4F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EAF1C4F
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. FLUCORTAC 50 microgrammes, comprimé sécable, Cellulose microcristalline 50 microgrammes

    H.A.C.

    Neurogenic Orthostatic Hypotension

    approved small molecule active

    1 trial

Frequently asked questions

What is H.A.C.?

H.A.C. (EAF1C4F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does H.A.C. sponsor?

We track 1 ClinicalTrials.gov-linked program for H.A.C., including FLUCORTAC 50 microgrammes, comprimé sécable, Cellulose microcristalline 50 microgrammes. Open each program for phase, modality, NCT IDs, and indication details.

Where does H.A.C. company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.